Abstract
GM3 synthase (GM3S) is a sialyltransferase that transfers sialic acid from CMP-sialic acid to lactosylceramide. This reaction results in formation of ganglioside GM3 and is essential for biosynthesis of its downstream derivatives, which include a- and b-series gangliosides. Here, we describe a method for GM3S enzymatic assay using fluorescence-labeled alkyl lactoside as acceptor substrate, followed by HPLC for separation of enzymatic product. The method allows quantitative assay of GM3S sialyltransferase activity in cultured cells and mouse brain tissues.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Inokuchi J, Inamori K, Kabayama K, Nagafuku M, Uemura S, Go S, Suzuki A, Ohno I, Kanoh H, Shishido F (2018) Biology of GM3 ganglioside. Prog Mol Biol Transl Sci 156:151–195. https://doi.org/10.1016/bs.pmbts.2017.10.004
Schnaar RL (2019) The biology of gangliosides. Adv Carbohydr Chem Biochem 76:113–148. https://doi.org/10.1016/bs.accb.2018.09.002
Groux-Degroote S, Rodriguez-Walker M, Dewald JH, Daniotti JL, Delannoy P (2018) Gangliosides in cancer cell signaling. Prog Mol Biol Transl Sci 156:197–227. https://doi.org/10.1016/bs.pmbts.2017.10.003
Nordstrom V, Willershauser M, Herzer S, Rozman J, von Bohlen Und Halbach O, Meldner S, Rothermel U, Kaden S, Roth FC, Waldeck C, Gretz N, de Angelis MH, Draguhn A, Klingenspor M, Grone HJ, Jennemann R (2013) Neuronal expression of glucosylceramide synthase in central nervous system regulates body weight and energy homeostasis. PLoS Biol 11(3):e1001506. https://doi.org/10.1371/journal.pbio.1001506
Ji S, Tokizane K, Ohkawa Y, Ohmi Y, Banno R, Okajima T, Kiyama H, Furukawa K, Furukawa K (2016) Increased a-series gangliosides positively regulate leptin/Ob receptor-mediated signals in hypothalamus of GD3 synthase-deficient mice. Biochem Biophys Res Commun 479(3):453–460. https://doi.org/10.1016/j.bbrc.2016.09.077
Inamori K, Ito H, Tamura Y, Nitta T, Yang X, Nihei W, Shishido F, Imazu S, Tsukita S, Yamada T, Katagiri H, Inokuchi J (2018) Deficient ganglioside synthesis restores responsiveness to leptin and melanocortin signaling in obese KKAy mice. J Lipid Res 59(8):1472–1481. https://doi.org/10.1194/jlr.M085753
Yoon SJ, Nakayama K, Hikita T, Handa K, Hakomori S (2006) Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptor. Proc Natl Acad Sci U S A 103(50):18987–18991. https://doi.org/10.1073/pnas.0609281103
Kabayama K, Sato T, Saito K, Loberto N, Prinetti A, Sonnino S, Kinjo M, Igarashi Y, Inokuchi J (2007) Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance. Proc Natl Acad Sci U S A 104(34):13678–13683. https://doi.org/10.1073/pnas.0703650104
Coskun U, Grzybek M, Drechsel D, Simons K (2011) Regulation of human EGF receptor by lipids. Proc Natl Acad Sci U S A 108(22):9044–9048. https://doi.org/10.1073/pnas.1105666108
Nagafuku M, Sato T, Sato S, Shimizu K, Taira T, Inokuchi J (2015) Control of homeostatic and pathogenic balance in adipose tissue by ganglioside GM3. Glycobiology 25(3):303–318. https://doi.org/10.1093/glycob/cwu112
Kanoh H, Nitta T, Go S, Inamori K, Veillon L, Nihei W, Fujii M, Kabayama K, Shimoyama A, Fukase K, Ohto U, Shimizu T, Watanabe T, Shindo H, Aoki S, Sato K, Nagasaki M, Yatomi Y, Komura N, Ando H, Ishida H, Kiso M, Natori Y, Yoshimura Y, Zonca A, Cattaneo A, Letizia M, Ciampa M, Mauri L, Prinetti A, Sonnino S, Suzuki A, Inokuchi J (2020) Homeostatic and pathogenic roles of GM3 ganglioside molecular species in TLR4 signaling in obesity. EMBO J 39(12):e101732. https://doi.org/10.15252/embj.2019101732
Simpson MA, Cross H, Proukakis C, Priestman DA, Neville DC, Reinkensmeier G, Wang H, Wiznitzer M, Gurtz K, Verganelaki A, Pryde A, Patton MA, Dwek RA, Butters TD, Platt FM, Crosby AH (2004) Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Genet 36(11):1225–1229. https://doi.org/10.1038/ng1460
Trinchera M, Parini R, Indellicato R, Domenighini R, dall’Olio F (2018) Diseases of ganglioside biosynthesis: an expanding group of congenital disorders of glycosylation. Mol Genet Metab 124(4):230–237. https://doi.org/10.1016/j.ymgme.2018.06.014
Yamashita T, Hashiramoto A, Haluzik M, Mizukami H, Beck S, Norton A, Kono M, Tsuji S, Daniotti JL, Werth N, Sandhoff R, Sandhoff K, Proia RL (2003) Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc Natl Acad Sci U S A 100(6):3445–3449. https://doi.org/10.1073/pnas.0635898100
Yoshikawa M, Go S, Takasaki K, Kakazu Y, Ohashi M, Nagafuku M, Kabayama K, Sekimoto J, Suzuki S, Takaiwa K, Kimitsuki T, Matsumoto N, Komune S, Kamei D, Saito M, Fujiwara M, Iwasaki K, Inokuchi J (2009) Mice lacking ganglioside GM3 synthase exhibit complete hearing loss due to selective degeneration of the organ of Corti. Proc Natl Acad Sci U S A 106(23):9483–9488. https://doi.org/10.1073/pnas.0903279106
Yang LJ, Zeller CB, Shaper NL, Kiso M, Hasegawa A, Shapiro RE, Schnaar RL (1996) Gangliosides are neuronal ligands for myelin-associated glycoprotein. Proc Natl Acad Sci U S A 93(2):814–818. https://doi.org/10.1073/pnas.93.2.814
Pan B, Fromholt SE, Hess EJ, Crawford TO, Griffin JW, Sheikh KA, Schnaar RL (2005) Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice. Exp Neurol 195(1):208–217. https://doi.org/10.1016/j.expneurol.2005.04.017
Collins BE, Yang LJ, Mukhopadhyay G, Filbin MT, Kiso M, Hasegawa A, Schnaar RL (1997) Sialic acid specificity of myelin-associated glycoprotein binding. J Biol Chem 272(2):1248–1255. https://doi.org/10.1074/jbc.272.2.1248
Paulson JC, Rademacher C (2009) Glycan terminator. Nat Struct Mol Biol 16(11):1121–1122. https://doi.org/10.1038/nsmb1109-1121
Bowser LE, Young M, Wenger OK, Ammous Z, Brigatti KW, Carson VJ, Moser T, Deline J, Aoki K, Morlet T, Scott EM, Puffenberger EG, Robinson DL, Hendrickson C, Salvin J, Gottlieb S, Heaps AD, Tiemeyer M, Strauss KA (2019) Recessive GM3 synthase deficiency: natural history, biochemistry, and therapeutic frontier. Mol Genet Metab 126(4):475–488. https://doi.org/10.1016/j.ymgme.2019.01.013
Boccuto L, Aoki K, Flanagan-Steet H, Chen CF, Fan X, Bartel F, Petukh M, Pittman A, Saul R, Chaubey A, Alexov E, Tiemeyer M, Steet R, Schwartz CE (2014) A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation. Hum Mol Genet 23(2):418–433. https://doi.org/10.1093/hmg/ddt434
Lee JS, Yoo Y, Lim BC, Kim KJ, Song J, Choi M, Chae JH (2016) GM3 synthase deficiency due to ST3GAL5 variants in two Korean female siblings: masquerading as Rett syndrome-like phenotype. Am J Med Genet A 170(8):2200–2205. https://doi.org/10.1002/ajmg.a.37773
Indellicato R, Parini R, Domenighini R, Malagolini N, Iascone M, Gasperini S, Masera N, dall’Olio F, Trinchera M (2019) Total loss of GM3 synthase activity by a normally processed enzyme in a novel variant and in all ST3GAL5 variants reported to cause a distinct congenital disorder of glycosylation. Glycobiology 29(3):229–241. https://doi.org/10.1093/glycob/cwy112
Heide S, Jacquemont ML, Cheillan D, Renouil M, Tallot M, Schwartz CE, Miquel J, Bintner M, Rodriguez D, Darcel F, Buratti J, Haye D, Passemard S, Gras D, Perrin L, Capri Y, Gerard B, Piton A, Keren B, Thauvin-Robinet C, Duffourd Y, Faivre L, Poe C, Perville A, Heron D, Thevenon J, Arnaud L, LeGuern E, La Selva L, Vetro A, Guerrini R, Nava C, Mignot C (2022) GM3 synthase deficiency in non-Amish patients. Genet Med 24(2):492–498. https://doi.org/10.1016/j.gim.2021.10.007
Miura Y, Yamagata T (1997) Glycosylation of lactosylceramide analogs in animal cells: amphipathic disaccharide primers for glycosphingolipid synthesis. Biochem Biophys Res Commun 241(3):698–703. https://doi.org/10.1006/bbrc.1997.7876
Watanabe S (2008) Synthesis of fluorescent alkyl lactoside derivatives. Carbohydr Res 343(13):2325–2328. https://doi.org/10.1016/j.carres.2008.05.008
Nihei W, Nagafuku M, Hayamizu H, Odagiri Y, Tamura Y, Kikuchi Y, Veillon L, Kanoh H, Inamori KI, Arai K, Kabayama K, Fukase K, Inokuchi J (2018) NPC1L1-dependent intestinal cholesterol absorption requires ganglioside GM3 in membrane microdomains. J Lipid Res 59(11):2181–2187. https://doi.org/10.1194/jlr.M089201
Uemura S, Yoshida S, Shishido F, Inokuchi J (2009) The cytoplasmic tail of GM3 synthase defines its subcellular localization, stability, and in vivo activity. Mol Biol Cell 20(13):3088–3100. https://doi.org/10.1091/mbc.E08-12-1219
Acknowledgments
This study was supported by JSPS KAKENHI, grant numbers JP21K06531 (K.-i.I.) and Grant-in-Aid for Scientific Research (B) from MEXT (20H03452), Takeda Foundation, and MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S1201031) (J.-i.I.). The authors are grateful to Dr. S. Anderson for English editing of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Inamori, Ki., Nitta, T., Shishido, F., Watanabe, S., Ohno, I., Inokuchi, Ji. (2023). Sialyltransferase Activity Assay for Ganglioside GM3 Synthase. In: Kabayama, K., Inokuchi, Ji. (eds) Glycolipids. Methods in Molecular Biology, vol 2613. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2910-9_9
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2910-9_9
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2909-3
Online ISBN: 978-1-0716-2910-9
eBook Packages: Springer Protocols